- Home
- UNCY vs NMT Comparison
UNCY vs NMT Comparison
Compare UNCY & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- NMT
- Stock Information
- Founded
- UNCY 2016
- NMT 1993
- Country
- UNCY United States
- NMT United States
- Employees
- UNCY N/A
- NMT N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- NMT Finance/Investors Services
- Sector
- UNCY Health Care
- NMT Finance
- Exchange
- UNCY Nasdaq
- NMT Nasdaq
- Market Cap
- UNCY 91.0M
- NMT 109.0M
- IPO Year
- UNCY 2021
- NMT N/A
- Fundamental
- Price
- UNCY $4.55
- NMT $11.76
- Analyst Decision
- UNCY Strong Buy
- NMT
- Analyst Count
- UNCY 4
- NMT 0
- Target Price
- UNCY $63.75
- NMT N/A
- AVG Volume (30 Days)
- UNCY 1.5M
- NMT 19.1K
- Earning Date
- UNCY 08-13-2025
- NMT 01-01-0001
- Dividend Yield
- UNCY N/A
- NMT 3.21%
- EPS Growth
- UNCY N/A
- NMT N/A
- EPS
- UNCY N/A
- NMT N/A
- Revenue
- UNCY N/A
- NMT N/A
- Revenue This Year
- UNCY N/A
- NMT N/A
- Revenue Next Year
- UNCY $1,458.53
- NMT N/A
- P/E Ratio
- UNCY N/A
- NMT N/A
- Revenue Growth
- UNCY N/A
- NMT N/A
- 52 Week Low
- UNCY $2.02
- NMT $9.05
- 52 Week High
- UNCY $11.00
- NMT $10.93
- Technical
- Relative Strength Index (RSI)
- UNCY 39.53
- NMT 48.23
- Support Level
- UNCY $4.76
- NMT $11.61
- Resistance Level
- UNCY $7.15
- NMT $11.85
- Average True Range (ATR)
- UNCY 0.97
- NMT 0.15
- MACD
- UNCY -0.28
- NMT -0.00
- Stochastic Oscillator
- UNCY 7.37
- NMT 56.41
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About NMT Nuveen Massachusetts Quality Municipal Income Fund
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes by investing in a portfolio of municipal obligations issued by state and local government authorities within a single state or certain U.S. territories.